Our commitment to regulatory excellence, transparency, and investor protection guides every aspect of our operations.
We operate within a comprehensive compliance framework that exceeds industry standards and regulatory requirements.
All our investment offerings are structured in compliance with SEC regulations, including Regulation D exemptions for private placements to accredited investors.
Our international operations comply with local regulations in each jurisdiction, including GMP, GACP, and pharmaceutical manufacturing standards.
We strictly operate within cannabis frameworks, ensuring all partners hold valid licenses and comply with local cannabis laws.
We maintain rigorous AML and KYC procedures to ensure the integrity of our investor base and comply with financial regulations.
Our Know Your Customer process includes:
Our Anti-Money Laundering program includes:
Our investment opportunities are available exclusively to qualified accredited investors as defined by the Securities and Exchange Commission.
To qualify as an accredited investor, an individual must meet ONE of the following criteria:
Option 1 - Income Test:
Individual income exceeding $200,000 in each of the two most recent years (or $300,000 jointly with spouse) and a reasonable expectation of reaching the same income level in the current year.
Option 2 - Net Worth Test:
Individual or joint net worth exceeding $1,000,000, excluding the value of primary residence.
Option 3 - Professional Certification:
Hold in good standing a Series 7, 65, or 82 license.
The following entity types may qualify as accredited investors:
Investing in cannabis involves significant risks, including the potential loss of your entire investment. Before investing, you should carefully consider whether these investments are suitable for you in light of your financial condition, investment experience, and risk tolerance. Please read all offering documents carefully and consult with your legal, tax, and financial advisors.
Despite the legalization of cannabis in many U.S. states and international jurisdictions, cannabis remains a Schedule I controlled substance under the U.S. Controlled Substances Act. This creates a conflict between state and federal law. SMPR operates exclusively in jurisdictions where cannabis is legal under state or local law, and we only partner with fully licensed operators. However, investors should be aware that federal enforcement priorities may change, and this could impact the operations of portfolio companies and the value of investments.
We strongly recommend that all investors consult with legal counsel familiar with cannabis law before making an investment decision.
Our compliance team is available to address any questions about regulatory requirements, eligibility, or our legal framework.